Mirati Therapeutics‘ (MRTX) pain continued Thursday amid a series of analyst downgrades after MRTX stock lost about half of its value in three days. X Earlier this week, Mirati said 49% of patie...
Tag: MRTX
MRTX Stock Crashes As Amgen Rivalry Heats Up With New Lung Cancer Data
Mirati Therapeutics (MRTX) said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed Tuesday as investors questioned whether it could take on traditional chemotherapy. ...
MRTX Stock Surges On Potential Big Pharma Buyout
A slew of Big Pharma suitors could be looking to buy Mirati Therapeutics (MRTX), according to reports that sent MRTX stock close to a breakout Wednesday. X Bloomberg reported Tuesday that Mirati has d...